Standardization of Extrusion Parameters During Liposomal Oxaliplatin Creation

The article is dedicated to development of anticancer drug oxaliplatin in liposomal form. The drug is prospective from point of view of use in clinical practice as a form of low-toxic cytostatic drug for anticancer therapy. The principles for development of the lipid particles and impotence of their size for the formulation with high level of encapsulation is discussed. Parameters of high pressure homogenization techniques were researched. Method was standardized in field of the process parameters. Finished product was characterized by following parameters: size of the liposomes, encapsulation degree and zeta potential.